20.6% Below Target

The consensus Wall Street price target for HBAN is $20.33, representing 20.6% upside from the current price of $16.86. With 48 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

HBAN has a consensus rating of "Buy" based on 48 Wall Street analysts. The rating breakdown is predominantly bullish, with 25 Buy/Strong Buy ratings. The consensus 12-month price target of $20.33 implies 20.6% upside from current levels.

With a forward P/E of 11.4321x, HBAN trades at a relatively low valuation. The consensus target of $20.33 implies 20.6% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $21 for HBAN, while the most conservative target is $18. The consensus of $20.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $28 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

HBAN is heavily covered by Wall Street, with 48 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 24 have Buy ratings, 20 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month HBAN stock forecast based on 48 Wall Street analysts shows a consensus price target of $20.33, with estimates ranging from $18 (bear case) to $21 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $21, with bear/bull scenarios of $14/$28.

Our quantitative valuation model calculates HBAN's fair value at $21 (base case), with a bear case of $14 and bull case of $28. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.

HBAN trades at a forward P/E ratio of 11.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 12.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on HBAN, with a "Buy" consensus rating and $20.33 price target (20.6% upside). 25 of 48 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

HBAN analyst price targets range from $18 to $21, a 15% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $20.33 consensus represents the middle ground. Our model's $14-$28 range provides an independent fundamental perspective.